In contrast, addition of a neutralizing IL-21 antibody to cultures of TILs isolated from patients with sporadic CRC and maximally activated with anti-CD3/CD28 reduced IL-17A and IL-22 production. The gene discussed is CD28; the disease is colorectal carcinoma.